The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Microbiology of airway disease in patients with cystic fibrosis
Open accessAbstract
Individuals with cystic fibrosis have abbreviated life spans primarily due to chronic airway infection. A limited number of types of organisms are responsible for these infections, with Staphylococcus aureus and Pseudomonas aeruginosa being of primary importance. In the pre-antibiotic era, greater than 90% of deaths due to infection were caused by S. aureus and death usually occurred in the first 2 years of life. With the advent of effective antistaphylococcal therapy, life spans increased and P. aeruginosa became the pathogen of primary importance. P. aeruginosa isolates recovered from patients with cystic fibrosis have a unique phenotypic characteristic referred to as "mucoid." The mucoid phenotype is due to the production of a mucoid exopolysaccharide. A mucoid exopolysaccharide is believed to play a central role in the establishment of chronic pseudomonal lung infection in these patients. A third organism, Pseudomonas cepacia, has recently been detected in the airways of older patients with cystic fibrosis and is associated with increased mortality. The virulence of P. cepacia is not understood, but the organism is extremely refractory to antimicrobial therapy. Other bacteria, including Haemophilus influenzae and members of the family Enterobacteriaceae, appear to play a secondary role in airway infection. Aspergillus fumigatus is the most important fungal agent causing allergic bronchopulmonary disease. The role of viruses has only recently been examined. At least in some patients with cystic fibrosis, respiratory syncytial virus may be important in predisposing to subsequent bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE: A CLINICAL AND PATHOLOGIC STUDY
ANDERSEN, D. H. (1938) · American Journal of Diseases of Children · doi:10.1001/archpedi.1938.01980140114013 · Cited by 1,146
Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P., & Levison, H. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80993-2 · Cited by 846
Lam, J., Chan, R., Lam, K., & Costerton, J. W. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.546-556.1980 · Cited by 649
Boucher, R. C., Stutts, M. J., Knowles, M. R., Cantley, L., & Gatzy, J. T. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112708 · Cited by 575
Altered Regulation of Airway Epithelial Cell Chloride Channels in Cystic Fibrosis
Frizzell, R. A., Rechkemmer, G., & Shoemaker, R. L. (1986) · Science · doi:10.1126/science.2425436 · Cited by 562
Cystic Fibrosis Locus Defined by a Genetically Linked Polymorphic DNA Marker
Tsui, L.-C., Buchwald, M., Barker, D., Braman, J. C., Knowlton, R., Schumm, J. W., Eiberg, H., Mohr, J., Kennedy, D., Plavsic, N., et al. (1985) · Science · doi:10.1126/science.2997931 · Cited by 504
Abnormal Ion Permeation Through Cystic Fibrosis Respiratory Epithelium
Knowles, M. R., Stutts, M. J., Spock, A., Fischer, N., Gatzy, J. T., & Boucher, R. C. (1983) · Science · doi:10.1126/science.6308769 · Cited by 485
Cited by
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
The role of bacterial biofilms in chronic infections
Bjarnsholt, T. (2013) · APMIS · doi:10.1111/apm.12099 · Cited by 1,080
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Why chronic wounds will not heal: a novel hypothesis
Bjarnsholt, T., Kirketerp‐Møller, K., Jensen, P. Ø., Madsen, K. G., Phipps, R., Krogfelt, K., Høiby, N., & Givskov, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00283.x · Cited by 886
Diversity and significance of Burkholderia species occupying diverse ecological niches
Coenye, T., & Vandamme, P. (2003) · Environmental Microbiology · doi:10.1046/j.1462-2920.2003.00471.x · Cited by 861
Primary Ciliary Dyskinesia: Diagnostic and Phenotypic Features
Noone, P. G., Leigh, M. W., Sannuti, A., Minnix, S. L., Carson, J. L., Hazucha, M., Zariwala, M. A., & Knowles, M. R. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-365oc · Cited by 843
Pathogenicity Islands in BacterialPathogenesis
Schmidt, H., & Hensel, M. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.14-56.2004 · Cited by 776
“aeruginosa infections are difficult to treat since this organism can express multiple antibiotic resistance factors (28, 53, 97, 114, 118, 358).”
BackgroundCystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1845pp · Cited by 738
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N., & Molin, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2907 · Cited by 715
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Applying insights from biofilm biology to drug development — can a new approach be developed?
Bjarnsholt, T., Ciofu, O., Molin, S., Givskov, M., & Høiby, N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4000 · Cited by 516
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Malhotra, S., Hayes, D., & Wozniak, D. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00138-18 · Cited by 515
Targeted Photothermal Lysis of the Pathogenic Bacteria, Pseudomonas aeruginosa, with Gold Nanorods
Norman, R. S., Stone, J. W., Gole, A., Murphy, C. J., & Sabo-Attwood, T. L. (2008) · Nano Letters · doi:10.1021/nl0727056 · Cited by 503
Bjarnsholt, T., Jensen, P. Ø., Burmølle, M., Hentzer, M., Haagensen, J. A. J., Hougen, H. P., Calum, H., Madsen, K. G., Moser, C., Molin, S., et al. (2005) · Microbiology · doi:10.1099/mic.0.27463-0 · Cited by 500
Taxonomy and Identification of the Burkholderia cepacia Complex
Coenye, T., Vandamme, P., Govan, J. R. W., & LiPuma, J. J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3427-3436.2001 · Cited by 432
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., Ramsey, B. W., & Clausen, C. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514631 · Cited by 421
Contribution of Quorum Sensing to the Virulence of Pseudomonas aeruginosa in Burn Wound Infections
Rumbaugh, K. P., Griswold, J. A., Iglewski, B. H., & Hamood, A. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.5854-5862.1999 · Cited by 408
“The extracellular virulence factors include exotoxin A, exoenzyme S, elastases (LasA and LasB), alkaline protease, and phospholipase C (3, 14, 17, 22, 46).”
BackgroundMechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W., & Deretic, V (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8377 · Cited by 392
Harris, J. K., De Groote, M. A., Sagel, S. D., Zemanick, E. T., Kapsner, R., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709804104 · Cited by 372
Kahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism
Kerem, E., Bistritzer, T., Hanukoglu, A., Hofmann, T., Zhou, Z., Bennett, W., MacLaughlin, E., Barker, P., Nash, M., Quittell, L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410304 · Cited by 356
Tobramycin Solution for Inhalation Reduces Sputum Pseudomonas aeruginosa Density in Bronchiectasis
BARKER, A. F., COUCH, L., FIEL, S. B., GOTFRIED, M. H., ILOWITE, J., MEYER, K. C., O'DONNELL, A., SAHN, S. A., SMITH, L. J., STEWART, J. O., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9910086 · Cited by 337
Saiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
Knowles, M. R., Robinson, J. M., Wood, R. E., Pue, C. A., Mentz, W. M., Wager, G. C., Gatzy, J. T., & Boucher, R. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119802 · Cited by 298
Burns, J. L., Van Dalfsen, J. M., Shawar, R. M., Otto, K. L., Garber, R. L., Quan, J. M., Montgomery, A. B., Albers, G. M., Ramsey, B. W., & Smith, A. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314727 · Cited by 289
Airway Mucus: From Production to Secretion
Williams, O. W., Sharafkhaneh, A., Kim, V., Dickey, B. F., & Evans, C. M. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0436sf · Cited by 284
Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis
Cimon, B., Carrère, J., Vinatier, J. F., Chazalette, J. P., Chabasse, D., & Bouchara, J. P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050011 · Cited by 271
Coenye, T., Goris, J., Spilker, T., Vandamme, P., & LiPuma, J. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2062-2069.2002 · Cited by 264
Chmiel, J. F., & Davis, P. B. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-8 · Cited by 254
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
Häußler, S., Ziegler, I., Löttel, A., Götz, F. V., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B., & Steinmetz, I. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05069-0 · Cited by 228
Mowat, E., Rajendran, R., Williams, C., McCulloch, E., Jones, B., Lang, S., & Ramage, G. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02130.x · Cited by 199
Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa
Häußler, S. (2004) · Environmental Microbiology · doi:10.1111/j.1462-2920.2004.00618.x · Cited by 143
Zhao, J., Cheng, W., He, X., & Liu, Y. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.010 · Cited by 39
Rosadini, C. V., Gawronski, J. D., Raimunda, D., Argüello, J. M., & Akerley, B. J. (2011) · Infection and Immunity · doi:10.1128/iai.05135-11 · Cited by 38
Metadata
- Authors
- Gilligan, P. H.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1991-01
- Volume
- 4
- Issue
- 1
- Pages
- 35-51
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2171315493
- Cited by
- 529
- References
- 103
- FWCI
- 26.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.